Ting‐Yi Chiang

Chi Mei Medical Center

Papers

1

Total Citations

2

H-Index

1

About

Ting‐Yi Chiang is a pioneering urologic surgeon whose work centers on advancing minimally invasive techniques for renal cancer treatment. His research focuses on the intersection of robotic surgery, fluorescence imaging, and superselective embolization to improve outcomes in complex nephron-sparing procedures. Chiang’s major contribution is the development of a retroperitoneal approach for indocyanine green (ICG) fluorescence-guided embolization in totally endophytic renal masses during robot-assisted partial nephrectomy (RAPN). His landmark 2024 study, which has already garnered 2 citations, demonstrated the feasibility of superselective transarterial ICG-lipiodol delivery to precisely localize and resect challenging tumors while minimizing damage to healthy kidney tissue. This work represents a significant step forward in preserving renal function and reducing surgical morbidity. Chiang’s innovative integration of interventional radiology and robotic surgery has positioned him as a leader in the field, offering new hope for patients with complex renal masses. His ongoing research continues to push the boundaries of what is possible in urologic oncology, making him a notable figure for students and researchers interested in the future of precision surgery.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Pioneering the retroperitoneal approach: Indocyanine green fluorescence-guided embolization in totally endophytic renal masses during robot-assisted partial nephrectomy
2 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Chi Mei Medical Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago